Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion type Assertion NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_head.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_provenance.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion evidence source_evidence_literature NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_provenance.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion SIO_000772 20623637 NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_provenance.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion wasDerivedFrom befree-2016 NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_provenance.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion wasGeneratedBy ECO_0000203 NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_provenance.